Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 23, 2025Current Issues in Molecular BiologyOpen Access

From Amyloid to Synaptic Dysfunction: Biomarker-Driven Insights into Alzheimer’s Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

LALuisa AgnelloCGCaterina Maria GambinoACAnna Maria Ciaccio

Discussion

Loading...

Member takes

Overview

This review highlights established biomarkers and their role in diagnosing Alzheimer's disease, suggesting innovative approaches to improve patient outcomes.

Key Points

  • Alzheimer's disease is the leading neurodegenerative disorder, urgently requiring better diagnosis and monitoring.
  • Biomarker assessment, including tau and amyloid ratios, is essential for staging Alzheimer's disease progression.
  • Emerging biomarkers like SNAP-25 and TREM2 enhance early detection, shifting focus to plasma and neuron-derived samples.
  • This review underscores the importance of biomarkers in precision medicine and patient management for Alzheimer's disease.

Cite This Study

Agnello et al. (2025) studied this question.

synapsesocial.com/papers/689a0621e6551bb0af8cdca3https://doi.org/10.3390/cimb47080580
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1[Current Status and Future Perspectives of Biomarkers in Alzheimer's Disease Diagnosis].2025
  2. 2Potential diagnostic markers in Alzheimer's disease: current perspectives and future directions2025 · 5 citations
  3. 3The Role of Blood-Based Biomarkers in Transforming Alzheimer’s Disease Research and Clinical Management: A Review2025 · 18 citations
  4. 4Proteome-Based Biomarkers for Alzheimer’s Disease: Old Acquisitions and Innovative Proposals2025 · 1 citations
  5. 5Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and Prognostics2024 · 13 citations